ATBECHDEDKESFR..GRITLILUNLSEMCPTIESILTLVFIRO..CY..TRBGCZEEHUPLSK....IS..MT..........................*JJDIM360 Ver 1.28 (29 Oct 2014) - 2999001/0The file contains technical information submitted after the application was filed and not included in this specification1991263CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120150225W184deBibliographieenBibliographyfrBibliographieEP07752174.8200703012008092520090317enenen778471 P20060301US784576 P20060321US39621620060330US39519720060330US2015022520150920081119200847201412242014522014070820150225201509A61K 39/02 20060101AFI20080926BHEP C12N 15/74 20060101ALI20080926BHEP deMANIPULIERTE LISTERIEN UND ANWENDUNGSVERFAHREN DAFÜRenENGINEERED LISTERIA AND METHODS OF USE THEREOFfrLISTÉRIA GÉNÉTIQUEMENT MODIFIÉE ET PROCÉDÉS POUR SON UTILISATIONWO-A-2004/110481WO-A-2005/071088BROCKSTEDT DIRK G ET AL: "Recombinant listeria monocytogenes-based immunotherapy targeting mesothelin for the treatment of pancreatic and ovarian cancer." PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING, vol. 46, April 2005 (2005-04), page 1418, XP001536813 & 96TH ANNUAL MEETING OF THE AMERICAN-ASSOCIATION-FOR-CANCER-RESEARCH; ANAHEIM, CA, USA; APRIL 16 -20, 2005 ISSN: 0197-016XBROCKSTEDT D G ET AL: "Listeria-based cancer vaccines that segregate immunogenicity from toxicity" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 101, no. 38, 21 September 2004 (2004-09-21), pages 13832-13837, XP002305523 ISSN: 0027-842414193181.620141114DUBENSKY, Thomas, W., Jr.15 King AvenuePiedmont, CA 94611USSKOBLE, Justin2423 Roosevelt AvenueBerkeley, CA 94703USLAUER, Peter, M.1003 Solano AvenueAlbany, CA 94706USCOOK, David, N.1975 Marion CourtLafayette, CA 94549USAduro Biotech101159727AHB/FP6579767626 Bankcroft Way, Suite 3CBerkeley, California 94710-2225USBrasnett, Adrian Hughet al100034516Mewburn Ellis LLP 33 Gutter LaneLondon EC2V 8ASGBATBEBGCHCYCZDEDKEEESFIFRGRHUIEISITLILTLULVMCMTNLPLPTROSESISKTRUS200700545720070301enWO200710322520070913200737